Zepp Health Corporation ZEPP
$4.58
-$0.37-7.48%
NYSE
| 12/31/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -18.97% | -39.32% | -48.24% | -51.00% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -18.97% | -39.32% | -48.24% | -51.00% |
| Cost of Revenue | -- | -21.28% | -46.11% | -56.85% | -60.43% |
| Gross Profit | -- | -14.82% | -24.07% | -23.94% | -18.56% |
| SG&A Expenses | -- | 14.27% | 8.56% | 0.00% | -13.56% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | -9.09% | -28.47% | -40.04% | -47.21% |
| Operating Income | -- | -93.86% | -105.23% | -55.01% | 8.36% |
| Income Before Tax | -- | -169.80% | -173.12% | -85.18% | 19.16% |
| Income Tax Expenses | -- | 370.54% | 992.71% | 663.46% | 152.07% |
| Earnings from Continuing Operations | -- | -192.15% | -213.04% | -143.72% | 0.91% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -39.11% | -38.75% | 13.25% | -67.65% |
| Net Income | -- | -192.63% | -213.73% | -144.00% | 0.73% |
| EBIT | -- | -93.86% | -105.23% | -55.01% | 8.36% |
| EBITDA | -- | -152.29% | -164.67% | -79.77% | 8.78% |
| EPS Basic | -- | -195.24% | -207.26% | -130.94% | 6.14% |
| Normalized Basic EPS | -- | -96.24% | -96.24% | -94.32% | 26.24% |
| EPS Diluted | -- | -181.02% | -192.40% | -122.46% | 3.57% |
| Normalized Diluted EPS | -- | -95.86% | -95.86% | -94.09% | 26.29% |
| Average Basic Shares Outstanding | -- | 2.09% | 4.52% | 6.39% | 4.41% |
| Average Diluted Shares Outstanding | -- | 0.79% | 3.17% | 4.99% | 3.04% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |